Trevi Therapeutics Inc Financial Flexibility Index
Trevi Therapeutics Inc financial flexibility index. Trevi Therapeutics Inc (TRVI) has a Financial Flexibility Index of -1.92x as of June 2026. Free cash flow of $-17.30 Million (operating CF $-17.43 Million minus capex $124.00K) represents -2% of total liabilities ($9.01 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Trevi Therapeutics Inc (2016–2025)
Financial flexibility index of Trevi Therapeutics Inc from 2016 to 2025. Historical Financial Flexibility Index trend for Trevi Therapeutics Inc across 10 annual periods. Explore TRVI cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Trevi Therapeutics Inc Financial Flexibility Index by Year (2016–2025)
Trevi Therapeutics Inc financial flexibility index by year from 2016 to 2025. Year-by-year free cash flow to debt coverage for Trevi Therapeutics Inc. For the full cash flow conversion analysis, see Trevi Therapeutics Inc (TRVI) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.13x | $-42.08 Million | $-42.09 Million | $10.20 Million | ▼ -21.5% |
| 2024 | -3.40x | $-38.22 Million | $-38.26 Million | $11.26 Million | ▲ +26.3% |
| 2023 | -4.61x | $-31.57 Million | $-31.71 Million | $6.86 Million | ▼ -155.7% |
| 2022 | -1.80x | $-28.02 Million | $-28.18 Million | $15.56 Million | ▼ -33.9% |
| 2021 | -1.35x | $-28.79 Million | $-28.95 Million | $21.40 Million | ▲ +7.8% |
| 2020 | -1.46x | $-28.97 Million | $-29.00 Million | $19.85 Million | ▲ +65.5% |
| 2019 | -4.23x | $-23.08 Million | $-23.09 Million | $5.46 Million | ▲ +25.8% |
| 2018 | -5.70x | $-18.13 Million | $-18.29 Million | $3.18 Million | ▼ -433.2% |
| 2017 | -1.07x | $-7.96 Million | $-7.97 Million | $7.45 Million | ▼ -146.8% |
| 2016 | -0.43x | $-11.18 Million | $-11.19 Million | $25.82 Million | — |